Novartis is running out of options in its bid to defend oral muscular sclerosis therapy Gilenya from early generic competition in the US. The US Court of Appeals for the Federal Circuit (CAFC) has ...

It has been reported that Novo Nordisk may have inadvertently allowed generics of its GLP-1 agonist semaglutide, the active ingredient in diabetes therapy Ozempic and ...

Anand Khanse is the Admin of TheWindowsClub.com, a 10-year Microsoft MVP (2006-16) & a Windows Insider MVP (2016-2022). Please read the entire post & the comments ...

Dr Reddy's Laboratories on Saturday said it has launched Dimethyl Fumarate delayed-release capsules, used to treat multiple sclerosis (MS), in the US market. The company's product is a therapeutic ...

8 budget ways to upgrade your dining table! Donald Trump pardoning Republicans sentenced to prison sparks fury Why most people fall off a ‘health cliff’ at 75 — and 5 ways to avoid the drop Emu runs ...